Pharma Manufacturing SA
11.3 FTEPharma Manufacturing reported revenue of €3.02m for the 2025 financial year (annual accounts filed with the NBB on 30 Sep 2026), with 11.3 full-time equivalents.
The score of Pharma Manufacturing shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Revenue +4 % Equity +1 % Total assets +2 % Headcount (avg FTE) +16 %
Accounts of the company itself (not consolidated).
The full file covers 9 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Pharma Manufacturing's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | €3.02m | ||||
| Net result | 6,229 € | ||||
| Equity | €2.77m | ||||
| Cash | 76,737 € | ||||
| EBITDA | 173,802 € | ||||
| Total assets | €2.97m |
Filed annual accounts
- Year ended 31 Dec 2025filed on 30 Sep 2026
- Year ended 31 Dec 2024filed on 30 Sep 2025
- Year ended 31 Dec 2023filed on 13 Oct 2024
- Year ended 31 Dec 2022filed on 21 Nov 2023
- Year ended 31 Dec 2021filed on 17 Oct 2022
Pharma Manufacturing's financial analysis
- Solvency93.1%sector median: 38.3%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Pharma Manufacturing
Pharma Manufacturing's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0475.313.955
- VAT number
- BE0475313955
- Peppol
- Registered · 0208:0475313955 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 16 Jul 2001
- Registered office
- 5032 Gembloux
- Size
- Small · 11.3 FTE
- Latest accounts
- 2025 · filed on 30 Sep 2026
- Activity
- Manufacture of homogenised food preparations and dietetic food (NACE 10860)
Pharma Manufacturing (SA) has been based in Gembloux since 2001, active in: manufacture of homogenised food preparations and dietetic food. For 2025, it reports revenue of €3.02m, a net profit of 6,229 € and equity of €2.77m. With 11.3 full-time equivalents, it is a small enterprise by headcount. Its solvency stands at 93.1%, above the median of its sector (38.3%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Pharma Manufacturing
Companies in the same business, of comparable size and area, outside its group.
- Be-Life Manufacture of homogenised food preparations and dietetic food Gembloux · balance sheet €9.52m
- NHM Natural Health Means Other non-specialised retail sale Gembloux · balance sheet 146,380 €
- Food Blending Manufacture of homogenised food preparations and dietetic food Evergem · balance sheet €1.52m
- Aero66 Manufacture of homogenised food preparations and dietetic food Vilvoorde · balance sheet 70,101 €
- Orthofood'S Laboratoires Manufacture of homogenised food preparations and dietetic food Charleroi · balance sheet €1.18m
- La VIE EST Belle Manufacture of homogenised food preparations and dietetic food Oostkamp · balance sheet €2.27m
- Le Chalet Manufacture of homogenised food preparations and dietetic food Olne · balance sheet 673,946 €
- Lifestylebrands Manufacture of homogenised food preparations and dietetic food Genk · balance sheet €1.72m
Frequently asked questions about Pharma Manufacturing
What is the revenue of Pharma Manufacturing?
According to the 2025 annual accounts filed with the NBB, the revenue of Pharma Manufacturing amounts to 3,023,045 €.
What is the VAT number of Pharma Manufacturing?
In Belgium, the VAT number is the company number prefixed with BE: BE0475313955 for Pharma Manufacturing, if the company is VAT-registered. Its company number (CBE) is 0475.313.955.
Where is the registered office of Pharma Manufacturing?
According to the CBE register, the registered office of Pharma Manufacturing is in 5032 Gembloux.
What is the equity of Pharma Manufacturing?
At the close of the 2025 financial year, the equity of Pharma Manufacturing amounts to 2,765,725 €, a solvency of 93.1% of total assets.
How many people work at Pharma Manufacturing?
11.3 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Pharma Manufacturing?
The register lists 5 active mandates at Pharma Manufacturing. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Pharma Manufacturing
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →